81154-09-8

Basic information

• Product Name: AKOS B018324
• Synonyms: (5E)-5-[(2-methoxyphenyl)methylene]-2-thioxo-thiazolidin-4-one;(5E)-5-[(2-methoxyphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one;IDI1_007801;Thiazolidin-4-one, 5-(2-methoxybenzylidene)-2-thioxo-;ZINC00976689;AKOS B018324;ART-CHEM-BB B018324;CHEMBRDG-BB 3018324
• CAS NO: 81154-09-8
• Molecular Formula: C11H9NO2S2
• Molecular Weight: 251.32
• Mol File: 81154-09-8.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 398.7°C at 760 mmHg
• Flash Point: 194.9°C
• Appearance: /
• Density: 1.42g/cm³
• Vapor Pressure: 1.44E-06mmHg at 25°C
• Refractive Index: 1.699
• CAS DataBase Reference: AKOS B018324(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS B018324(81154-09-8)
• EPA Substance Registry System: AKOS B018324(81154-09-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 81154-09-8(Hazardous Substances Data)

Usage

General Description

AKOS B018324 is a chemical compound with a unique identifier in the AKOS database. The specific composition and properties of this compound are not readily available, but it likely has industrial applications and may be used in pharmaceuticals, research, or other chemical processes. More detailed information about the exact nature of AKOS B018324 would be needed to determine its specific uses and potential hazards.

InChI:InChI=1/C11H9NO2S2/c1-14-8-5-3-2-4-7(8)6-9-10(13)12-11(15)16-9/h2-6H,1H3,(H,12,13,15)/b9-6+

Upstream product

• 141-84-4 2-thioxo-4-thiazolidinone 
• 135-02-4 ortho-anisaldehyde 

Relevant articles and documents

Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase

A series of rhodanine derivatives RB1–RB23 were synthesized through a two-round screening. Their Mycobacterial tuberculosis (Mtb) InhA inhibitory activity and Mtb growth blocking capability were evaluated. The most potent hit compound RB23 indicated compa

Molecular docking evaluation of (E)-5-arylidene-2-thioxothiazolidin-4-one derivatives as selective bacterial adenylate kinase inhibitors

Multi-drug resistant microorganism infections with emerging problems that require not only a prevention strategy, but also the development of new inhibitory compounds. Six previously synthesized 5-arylidene-2-thioxothiazolidin-4-one derivatives 1a–f, were

Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors

Abstract A type of novel rhodanine-based 4-anilinoquinazoline, which designed the combination between quinazoline as the backbone and various substituted biological rhodanine groups as the side chain, have been synthesized, and their antiproliferative act